Form 4 for GH Guardant Health, Inc.
Accepted 2024-10-01 00:00:00 ET · period of report 2024-09-30 · accession 0001576280-24-000226 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-01 | 2024-09-30 | GH | Eltoukhy Helmy | Co-CEO, Dir | M - OptEx | $0.00 | +11.5K | 2.31M | +0.5% | $0 |
| D | 2024-10-01 | 2024-09-30 | GH | Eltoukhy Helmy | Co-CEO, Dir | F - Tax | $22.94 | -5,809 | 2.30M | -0.3% | -$133.3K |
| D | 2024-10-01 | 2024-09-30 | GH | Eltoukhy Helmy | Co-CEO, Dir | M - OptEx | $0.00 | -11.5K | 11.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-30 | M | A | 11,461 | $0.00 | 2,310,075 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-30 | F | D | 5,809 | $22.94 | 2,304,266 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 3 | Derivative | Restricted Stock Units | 2024-09-30 | M | D | 11,461 | $0.00 | 11,462 | D | $0.00 · — to — | 11,461 Common Stock | (F2) This restricted stock unit award will vest in four equal installments on the last day of each calendar quarter, 3/31, 6/30, 9/30, and 12/31. (F3) Not applicable for Restricted Stock Units. |